ADMA Biologics Inc (NAS:ADMA)
$ 17.67 0.26 (1.49%) Market Cap: 4.12 Bil Enterprise Value: 4.14 Bil PE Ratio: 62.18 PB Ratio: 17.75 GF Score: 68/100

ADMA Biologics Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 09, 2021 / 04:30PM GMT
Release Date Price: $1.19 (+0.85%)
Andrew Christopher Ranieri
Morgan Stanley, Research Division - Equity Analyst

Thank you, everyone, for joining us today. I'm Drew Ranieri, a medical device analyst here at Morgan Stanley. It's my pleasure to have Adam Grossman, President and CEO; and Brian Lenz, EVP and CFO, from ADMA Biologics today.

Before we jump into Q&A, I just have to get the disclaimer out of the way first. But for important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.

With that out of the way, Adam, Brian, thanks so much for being with us today, looking forward to the conversation.

Questions & Answers

Andrew Christopher Ranieri
Morgan Stanley, Research Division - Equity Analyst

And really as an observer of the company, it looks like there's been a tremendous amount of progress on both the commercial side and operationally over the last 12 months. So you've essentially spent kind of the last

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot